Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.87%406.32M | -9.56%423.84M | 11.33%446.98M | 1.03%1.74B | 0.02%430.36M | -13.12%441.03M | 17.50%468.63M | 3.72%401.5M | 17.89%1.72B | 0.92%430.26M |
| Operating revenue | -7.87%406.32M | -9.56%423.84M | 11.33%446.98M | 1.03%1.74B | 0.02%430.36M | -13.12%441.03M | 17.50%468.63M | 3.72%401.5M | 17.89%1.72B | 0.92%430.26M |
| Cost of revenue | -12.36%259.68M | -3.34%289.19M | -4.79%277.35M | -5.21%1.16B | -14.67%270.57M | -1.38%296.3M | -0.20%299.17M | -4.08%291.3M | 44.14%1.22B | 3.42%317.08M |
| Gross profit | 1.32%146.65M | -20.54%134.65M | 53.93%169.63M | 16.18%584.17M | 41.18%159.79M | -30.13%144.74M | 71.06%169.45M | 32.12%110.2M | -18.26%502.8M | -5.48%113.18M |
| Operating expense | 35.44%36.4M | 8.60%37.41M | -8.64%35.41M | -7.48%136.78M | 20.36%35.3M | -30.90%26.88M | -11.97%34.44M | 1.12%38.76M | 61.74%147.84M | -17.07%29.33M |
| Selling and administrative expenses | 33.21%15.13M | 28.47%14.79M | -15.92%11.36M | 13.14%50.27M | 65.36%13.89M | 4.33%11.36M | -20.93%11.51M | 27.62%13.51M | 25.00%44.43M | -27.16%8.4M |
| -General and administrative expense | 33.21%15.13M | 28.47%14.79M | -15.92%11.36M | 13.14%50.27M | 65.36%13.89M | 4.33%11.36M | -20.93%11.51M | 27.62%13.51M | 25.00%44.43M | -27.16%8.4M |
| Other operating expenses | 37.07%21.27M | -1.37%22.62M | -4.74%24.05M | -16.34%86.51M | 2.30%21.41M | -44.60%15.52M | -6.67%22.93M | -8.99%25.25M | 85.12%103.41M | -12.19%20.93M |
| Operating profit | -6.46%110.24M | -27.97%97.25M | 87.88%134.22M | 26.04%447.4M | 48.47%124.49M | -29.95%117.86M | 125.27%135.01M | 58.47%71.44M | -32.22%354.96M | -0.62%83.85M |
| Net non-operating interest income (expenses) | -1.42%-21.44M | 15.57%-20.89M | 20.83%-19.19M | 12.83%-90.42M | 13.30%-21.7M | 21.71%-21.14M | 10.30%-24.74M | 7.12%-24.24M | -113.45%-103.72M | -8.04%-25.03M |
| Non-operating interest expense | -9.91%17.31M | -21.83%17.94M | -24.77%16.67M | -15.90%80.63M | -22.75%17.71M | -23.51%19.21M | -10.63%22.95M | -8.61%22.15M | 114.92%95.88M | 19.49%22.93M |
| Total other finance cost | 114.78%4.13M | 64.78%2.94M | 20.97%2.53M | 24.84%9.79M | 89.86%3.99M | -3.03%1.92M | -5.80%1.79M | 12.31%2.09M | 97.01%7.84M | --2.1M |
| Other net income (expenses) | -1,554.91%-412.82M | 426.42%38.3M | 69.74%-27.69M | -34.38%-147.66M | -409.81%-91.78M | 122.00%28.37M | 398.81%7.28M | -1,004.67%-91.52M | -260.95%-109.88M | 951.08%29.63M |
| Gain on sale of security | -137.49%-10.5M | 129.56%40.11M | 45.92%-28.94M | -488.83%-62.51M | -184.02%-54.48M | 177.55%28.01M | 500.41%17.47M | -545.87%-53.51M | 139.97%16.08M | 879.55%64.84M |
| Special income (charges) | -110,323.56%-402.32M | 82.24%-1.81M | 103.29%1.25M | 32.40%-85.15M | -5.92%-37.3M | 100.39%365K | -628.67%-10.2M | ---38.01M | -1,387.87%-125.95M | -828.08%-35.22M |
| -Gain on sale of property,plant,equipment | -110,323.56%-402.32M | 82.24%-1.81M | 103.29%1.25M | 32.40%-85.15M | -5.92%-37.3M | 100.39%365K | -628.67%-10.2M | ---38.01M | -754.34%-125.95M | -346.17%-35.22M |
| Income before tax | -359.01%-324.01M | -2.45%114.66M | 297.04%87.34M | 48.08%209.32M | -87.56%11M | 917.03%125.1M | 292.90%117.55M | -514.41%-44.33M | -68.21%141.36M | 53.22%88.44M |
| Income tax | -339.63%-75.25M | 25.44%28.43M | 299.27%23.08M | -0.13%47.1M | -85.15%4.62M | 756.55%31.4M | 441.74%22.66M | -241.39%-11.58M | -52.60%47.16M | 327.31%31.12M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -365.51%-248.77M | -9.12%86.24M | 296.24%64.26M | 72.21%162.22M | -88.87%6.38M | 985.17%93.69M | 268.71%94.89M | -1,407.15%-32.74M | -72.71%94.2M | 13.64%57.32M |
| Net income continuous operations | -365.51%-248.77M | -9.12%86.24M | 296.24%64.26M | 72.21%162.22M | -88.87%6.38M | 985.17%93.69M | 268.71%94.89M | -1,407.15%-32.74M | -72.71%94.2M | 13.64%57.32M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -365.51%-248.77M | -9.12%86.24M | 296.24%64.26M | 72.21%162.22M | -88.87%6.38M | 985.17%93.69M | 268.71%94.89M | -1,407.15%-32.74M | -72.71%94.2M | 13.64%57.32M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -365.51%-248.77M | -9.12%86.24M | 296.24%64.26M | 72.21%162.22M | -88.87%6.38M | 985.17%93.69M | 268.71%94.89M | -1,407.15%-32.74M | -72.71%94.2M | 13.64%57.32M |
| Diluted earnings per share | -394.12%-0.5 | 0.00%0.17 | 300.00%0.12 | 76.47%0.3 | -80.00%0.02 | 750.00%0.17 | 240.00%0.17 | -1,433.04%-0.06 | -77.33%0.17 | 42.86%0.1 |
| Basic earnings per share | -394.12%-0.5 | 0.00%0.17 | 300.00%0.12 | 76.47%0.3 | -80.00%0.02 | 750.00%0.17 | 240.00%0.17 | -1,442.58%-0.06 | -77.03%0.17 | 66.67%0.1 |
| Dividend per share | 2.00%0.0383 | 2.00%0.0383 | 2.00%0.0383 | 0.33%0.1505 | 1.33%0.038 | 0.00%0.0375 | 0.00%0.0375 | 0.00%0.0375 | 28.76%0.15 | 7.14%0.0375 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.